NYSE: AXTAAxalta

    Axalta merger with AkzoNobel moves toward early 2027 completion

    • US stocks
    • Mergers & acquisitions
    • Materials

    Axalta (NYSE: AXTA) is party to an all-stock merger of equals with AkzoNobel, and the filing sets out its pro forma effects, it said on 17 Nov 2026. The filing reports that AkzoNobel announced a notes offering on the same day, with net proceeds that may be used in part to refinance Axalta debt after completion. The company expects completion in early 2027, subject to regulatory approvals and other customary conditions.

    Key highlights

    • Exchange ratio: 0.6539 AkzoNobel shares per Axalta common share
    • Equity consideration: €6,378 million, preliminary
    • Pre-completion distribution reflected in pro forma: €2.2 billion
    • Transaction costs: €159 million, nonrecurring, estimated
    • Expected completion: early 2027

    The merger in numbers

    ItemDetail
    StructureAll-stock merger of equals
    Exchange ratio0.6539 AkzoNobel shares per Axalta common share
    Axalta common shares outstanding (30 Sep 2026)214 million
    Equity consideration (preliminary)€6,378 million
    Total preliminary purchase consideration€6,414 million, including €36 million stock-based compensation
    Pre-completion distribution in pro forma€2.2 billion, part of a planned €2.5 billion special dividend less 2026 regular dividends
    Notes that may be refinanced$500.0 million due 2027, $700.0 million due 2029, $500.0 million due 2031
    Expected completionEarly 2027

    Notes offering may refinance Axalta debt

    AkzoNobel announced the start of a notes offering on 17 Nov 2026. The notes are offered only to qualified institutional buyers under Rule 144A or to non-U.S. persons under Regulation S, and the filing says the offering is conducted solely by the issuer, which is not a member of the Axalta Group.

    The company says net proceeds are intended for general corporate purposes and may also refinance Axalta's term loans due 20 Dec 2029 and its senior notes due 2027, 2029 and 2031, following completion. The filing states that the Q3 2026 pro forma information does not include the effect of the notes offering.

    Pro forma figures and planned divestitures

    The pro forma information combines the two companies as if the merger had taken place on 30 Sep 2026 for the balance sheet and 1 Jan 2025 for the income statement. It is preliminary and illustrative and does not project future results. The filing reports pro forma combined revenue of €10,882 million for the nine months ended 30 Sep 2026.

    AkzoNobel plans to divest its European vehicle refinishing business and Axalta plans to divest its North American building products business, which the company describes as part of obtaining regulatory clearances.

    What the Axalta merger means for Axalta shareholders

    The filing does not state the cash value per Axalta share.

    The filing does not say whether regulatory approvals have been obtained, the exact completion date, the financial effect of the planned divestitures, the size or pricing of the notes, or any synergies. The next dated step given is completion, which the company expects in early 2027.

    Filed with the US SEC on . Reference: Original filing (SEC)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

    Latest posts